# Zainidip in Renal Artery Stenosis

> **NCT02594410** · PHASE4 · COMPLETED · sponsor: **Lee's Pharmaceutical Limited** · enrollment: 149 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DEVICE:** stent
- **DRUG:** Aspirine
- **DRUG:** Clopidogrel
- **DRUG:** Lercanidipine

## Key facts

- **NCT ID:** NCT02594410
- **Lead sponsor:** Lee's Pharmaceutical Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2014-03
- **Final completion:** 2014-05
- **Target enrollment:** 149 (ACTUAL)
- **Last updated:** 2015-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02594410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02594410, "Zainidip in Renal Artery Stenosis". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02594410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*